• SENSEX 73,055.43
    -193.96 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 970.70(%)
  • Eternal
    317.50 344.75(%)
  • IndusInd Bank
    832.00 750.45(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Group
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
828.80 -14 (-1.71%)
  • As on 23 Oct 2026 (EOD)
  • Today’s Low

    821.00
  • Today’s High

    844.00
  • Open

    840.00
  • Perv Close

    843.25
  • 52W Low

    585.00
  • 52W High

    1,002.40

Key Indicators

  • P/E(TTM)

    35.77

  • Mar.Cap (₹Cr.)

    7,515.54

  • Div & Yield %

    0.42

  • Book Value(₹)

    218.61

  • Debt-Equity Ratio

    -1.71

  • AGM Date

    22-Oct-2026

  • EPS

    23.18

  • P/E Ratio

    35.77

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    7,515.54

  • RONW (%)

    13.08

  • ROCE (%)

    16.60

Score Board

  • Equity (₹ in Cr.)

    45.34

  • BV (₹)

    218.60

  • Sales( ₹ in Cr.)

    1,797.55

  • NP (in Cr.)

    178.29

  • NP Var(%)

    -31.0

  • Div%

    70.0

  • CPS (₹)

    31.20

  • EPS (₹)

    19.70

  • Traded Value (₹ in Lakhs)

    7,517.81

  • 52 Week High

    1,002.40

  • 52 Week Low

    585.00

  • Price BSE

    829.0

  • Price NSE

    829.00

  • Market Capital( in Cr.)

    7,517.81

  • P/C Ratio

    26.60

  • P/E Ratio

    42.20

  • Price Vs.BV

    19.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,797.55 1,771.35 1,502.13 1,511.25 941.02 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,797.55 1,771.35 1,502.13 1,511.25 941.02 0.00
Other Income 15.32 12.80 11.01 1.28 2.51 0.00
Stock Adjustments 62.58 -47.85 23.36 91.22 32.54 0.00
Total Income 1,875.45 1,736.30 1,536.50 1,603.75 976.07 0.00
EXPENDITURE :            
Raw Materials 883.72 783.83 775.33 909.15 484.20 0.00
Power and Fuel Cost 87.88 80.19 82.92 74.22 43.43 0.00
Employee Cost 160.41 139.82 120.15 113.92 79.98 0.00
Other Manufacturing Expenses 219.02 188.62 109.26 91.11 164.69 0.00
Selling and Administration Expenses 77.85 78.30 66.55 82.93 21.46 0.00
Miscellaneous Expenses 61.14 24.51 25.13 22.80 0.01 0.00
Employee Benefit Expenses 160.41 139.82 120.15 113.92 79.98 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,490.02 1,295.27 1,179.33 1,294.14 793.78 0.00
Operating Profit 385.44 441.03 357.16 309.62 182.30 0.00
Interest 46.90 25.63 16.63 20.49 11.34 0.00
Gross Profit 338.54 415.40 340.53 289.13 170.96 0.00
Depreciation 104.30 79.06 66.01 55.77 37.23 0.00
Profit Before Tax 234.24 336.34 274.52 233.36 133.73 0.00
Current Tax 41.99 56.71 46.06 52.13 22.50 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 16.05 22.28 27.82 9.50 4.50 0.00
Reported Net Profit 176.20 257.35 200.65 171.73 106.73 0.00
Extraordinary Items -2.09 0.00 0.00 0.00 0.03 0.00
Adjusted Net Profit 178.29 257.35 200.65 171.73 106.70 0.00
Adjustment below Net Profit -1.29 -1.42 0.00 0.00 599.24 0.00
P & L Balance brought forward 1,266.28 1,042.07 859.55 705.95 -0.02 -0.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.21 31.72 18.13 18.13 0.00 0.00
P & L Balance carried down 1,404.97 1,266.28 1,042.07 859.55 705.95 -0.02
Dividend 0.00 0.00 0.00 18.13 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 70.00 100.00 60.00 40.00 0.00 0.00
Dividend Per Share(Rs) 3.50 5.00 3.00 2.00 0.00 0.00
Earnings Per Share-Unit Curr 19.44 28.39 22.14 18.95 4,269.05 -0.18
Earnings Per Share(Adj)-Unit Curr 19.44 28.39 22.14 18.95 - -
Book Value 218.66 203.44 178.92 158.74 49,558.52 9.07
Book Value(Adj)-Unit Curr 218.66 203.44 178.92 158.74 - -

Shareholding Pattern

  • Promoter Group

    39.66%

  • Public Share Holding

    60.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 155,737 155,737.00 155,737 155,737
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 155,737 0.17 155,737 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,830,025 5.33 4,830,025 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 25,152,803 27.74 25,152,803 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 5,825,860 6.42 5,825,860 5
Others 0 0.00 0 0
Sub Total 35,808,688 39.49 35,808,688 43
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,864 0.01 8,864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1 0.00 1 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,393,684 8.15 7,393,684 107
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,304,952 4.75 4,304,952 2
Mutual Funds / UTI 542,663 0.60 542,663 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,767,751 3.05 2,767,751 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,017,915 16.56 15,017,915 138
2] Non Institution
Bodies Corporate 3,678,625 4.06 3,678,625 1,235
Clearing Members 90,269 0.10 90,269 41
Directors of their Relatives 26,901 0.03 26,901 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,537,898 1.70 1,537,898 4,997
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,039,296 1.15 1,039,296 2,630
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,274,420 10.23 9,274,420 56
Individuals holding nominal share capital up to Rs. 1 lakh 23,052,532 25.42 23,052,532 165,037
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 21,764 0.02 21,764 5
Others 306,160 0.34 306,160 3
Sub Total 39,697,473 43.78 39,697,473 174,147
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 90,679,813 100.00 90,679,813 174,329

Company Background

Aarti Pharmalabs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aarti Pharmalabs Ltd
  • BSE Code : 75909.0
  • ISIN : INE0LRU01027
  • Incorporation Year

    2019

  • Registered Office

    Plot No 22/C/1 & 22/C/2
    1st Phase GIDC Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-22-6797 6666

  • FAX

    91-22-2565 3234

  • Chairman

    Rashesh C Gogri

  • Managing Director

    Hetal Gogri Gala

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Pharmalabs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Pharma 829.05 1,812.87 1,797.55 36.12 11.11
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77